The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi-experimental study.
- Resource Type
- Academic Journal
- Authors
- Langenberger B; Department of Health Care Management, Technische Universität Berlin, Berlin, Germany.; Baier N; Department of Global Health Economics, Kiel Institute for the World Economy, Kiel, Germany.; Hanke FC; General Management, Gero PharmCare GmbH, Köln, Germany.; Fahrentholz J; Long-term Care Services Management, AOK Nordost - Die Gesundheitskasse, Potsdam, Germany.; Gorny C; Long-term Care Services Management, AOK Nordost - Die Gesundheitskasse, Potsdam, Germany.; Sehlen S; Health Services Management, AOK Nordost - Die Gesundheitskasse, Potsdam, Germany.; Reber KC; Health Services Management, AOK Nordost - Die Gesundheitskasse, Potsdam, Germany.; Liersch S; Health Services Management, AOK Nordost - Die Gesundheitskasse, Potsdam, Germany.; Radomski R; Department of Innovative Health Services, VIACTIV Krankenkasse, Bochum, Germany.; Haftenberger J; Department of Contract Management, IKK Brandenburg und Berlin, Potsdam, Germany.; Heppner HJ; Department of Geriatrics, Universität Witten/Herdecke, Witten, Germany.; Clinic of Geriatrics, Helios Klinikum Schwelm, Schwelm, Germany.; Busse R; Department of Health Care Management, Technische Universität Berlin, Berlin, Germany.; Vogt V; Department of Health Care Management, Technische Universität Berlin, Berlin, Germany.
- Source
- Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101675107 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2054-1058 (Electronic) Linking ISSN: 20541058 NLM ISO Abbreviation: Nurs Open Subsets: MEDLINE
- Subject
- Language
- English
Aim: To estimate the cost-effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool.
Design: Multi-centred non-randomized controlled trial from August 2018 to March 2020 including 65 nursing homes or home care providers.
Methods: We aim to estimate the effect of the intervention on the rate of adverse drug events as primary outcome through a quasi-experimental empirical study design. As secondary outcomes, we use hospital admissions and falls. All outcomes will be measured on patient-month level. Once the causal effect of the intervention is estimated, cost-effectiveness will be calculated. For cost-effectiveness, we include all patient costs observed by the German statutory health insurance.
Results: The results of this study will inform about the cost-effectiveness of the optimized drug supply intervention and provide evidence for potential reimbursement within the German statutory health insurance system.
(© 2021 The Authors. Nursing Open published by John Wiley & Sons Ltd.)